Stay updated with breaking news from Bioscience price. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 836,800 shares, a growth of 19.4% from the August 15th total of 700,900 shares. Based on an average daily volume of 307,200 shares, […] ....
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) – Brookline Capital Management issued their Q3 2023 earnings estimates for Daré Bioscience in a report released on Monday, June 5th. Brookline Capital Management analyst K. Dolliver expects that the biotechnology company will earn ($0.07) per share for the quarter. Brookline Capital Management currently has a “Buy” rating […] ....
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 378,600 shares, a decrease of 25.9% from the April 30th total of 511,000 shares. Based on an average daily volume of 191,300 shares, the […] ....
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 612,400 shares, an increase of 12.5% from the March 31st total of 544,400 shares. Based on an average daily trading volume, of 283,800 shares, […] ....
HC Wainwright reissued their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Get Rating) in a report published on Friday morning, Benzinga reports. HC Wainwright currently has a $7.00 price objective on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s FY2027 earnings at $0.80 EPS. Several other equities research analysts […] ....